1. Home
  2. SNCR vs ONCY Comparison

SNCR vs ONCY Comparison

Compare SNCR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.46

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.95

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNCR
ONCY
Founded
2000
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
106.1M
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
SNCR
ONCY
Price
$8.46
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.00
AVG Volume (30 Days)
297.0K
667.3K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$170,909,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$3.98
$0.33
52 Week High
$12.85
$1.51

Technical Indicators

Market Signals
Indicator
SNCR
ONCY
Relative Strength Index (RSI) 74.58 44.25
Support Level $8.22 $0.92
Resistance Level $8.46 $1.06
Average True Range (ATR) 0.14 0.06
MACD 0.01 0.01
Stochastic Oscillator 40.77 35.19

Price Performance

Historical Comparison
SNCR
ONCY

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: